TrialThe Journal of clinical endocrinology and metabolism2018

Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus.

Hussein Al Jobori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.